Glucose Health EBITDA 2014-2019 | GLUC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Glucose Health ebitda from 2014 to 2019. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Glucose Health ebitda from 2014 to 2019. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$206.3B
Stryker (SYK)	$148B
Boston Scientific (BSX)	$133.7B
EssilorLuxottica (ESLOY)	$111.2B
Medtronic (MDT)	$110.6B
Haleon (HLN)	$44B
Lonza Group Ag (LZAGY)	$42.2B
GE HealthCare Technologies (GEHC)	$37.9B
ResMed (RMD)	$36.6B
Terumo (TRUMY)	$30.3B
Koninklijke Philips (PHG)	$25.5B
Zimmer Biomet Holdings (ZBH)	$22.3B
Insulet (PODD)	$18.7B
Baxter (BAX)	$17B
Smith & Nephew SNATS (SNN)	$11.2B
BellRing Brands (BRBR)	$9.9B
Bio-Rad Laboratories (BIO)	$9.5B
Demant (WILYY)	$8.3B
Lantheus Holdings (LNTH)	$6.3B
TG Therapeutics (TGTX)	$5.4B
Haemonetics (HAE)	$4.4B
Prestige Consumer Healthcare (PBH)	$4.2B
Perrigo (PRGO)	$3.9B
ICU Medical (ICUI)	$3.9B
Envista Holdings (NVST)	$3.8B
Agios Pharmaceuticals (AGIO)	$3.3B
Neogen (NEOG)	$3.1B
Shandong Weigao Medical Polymer (SHWGF)	$3B
GN Store Nord (GNNDY)	$2.9B
QuidelOrtho (QDEL)	$2.8B